Marinus Pharmaceuticals Inc. (MRNS) declined -13.71% or -0.72 to $4.53. It is around 4.66 million shares traded, which is 436.07% compare to the average total volume 1.07 million. The market cap of MRNS is $183.15 million. The year to date change is -37.5%. The 52 week price range is from $1.13 to $9.87. Price of MRNS have changed 0.77% during last week. It have changed -21.05% over last month, -21.52% over last 3 months, 77.97% over last 6 months N/A
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MRNS is 6.91. It is 52.54% above current price. The 200-day Moving Averages for MRNS is 4.62. It is 1.99% above current price. The 52-week High is 9.87. It is 117.88% from the current price. The 52-week Low is 1.13. It is -75.06% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of MRNS is 1.94 on 2018-02-15. Short % to float is 5.21%. There are some statistics of MRNS. It is has market cap $183.15 million. The share outstanding is 40.43 million. The average volume is 1.07 million. It has 118.10M cash and 13.11M in debt. The percent of top 15 Institution holding is 41.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MRNS is -45.44%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MRNS is -39.06%.